Taken together, the enhanced total tumour blood vessel density counts in vivo and increased microvessel sprouting ex vivo in Cldn14-hets indicate that partial, but not complete, loss of Cldn14 is sufficient to enhance angiogenic responses, but with compromised functionality. This evidence concerns the gene CLDN14 and neoplasm.